A Pilot Study to Investigate the Safety and Clinical Activity of Avelumab (MSB0010718C) in Thymoma and Thymic Carcinoma After Progression on Platinum-Based Chemotherapy

NCT03076554 · clinicaltrials.gov ↗

PHASE2

Phase

ACTIVE_NOT_RECRUITING

Status

56

Enrollment

NIH

Sponsor class

Conditions

Thymoma
Thymic Carcinoma

Interventions

DRUG: Avelumab

Sponsor

National Cancer Institute (NCI)